Drug Pipeline

Maraviroc Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
3
Recruiting
4
Top Sponsors
Active Studies by Phase
Phase 2
3
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06853223 This Study is Assessing the Safety and Efficacy of Immune Inhibition as a Treatment to… Primary Graft Dysfunction Recruiting
NCT06511063 Antiviral Clinical Trial for Long Covid-19 Long Covid Recruiting
NCT06805656 Multi Interventional Approaches to Mitigate HIV Reservoirs Aiming the Sustained HIV… Hiv Not Yet Recruiting
Phase 1/2
NCT05470491 Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell… HIV Recruiting
Sponsors Running Maraviroc Trials
National Cancer Institute (NCI) (1) Icahn School of Medicine at Mount Sinai (1) Federal University of São Paulo (1) University of California, San Francisco (1)
Get alerts when Maraviroc trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free